Search research articles
Contact Us
Filters
Showing results (231-240 of 692) with videos related to
Page
of 70
Sort By:
The Annals of Thoracic Surgery
|
May 30, 2017
Surgical Treatment of Complications After High-Dose Chemoradiotherapy for Lung Cancer
Chris Dickhoff, Max Dahele, Sayed M Hashemi, et al.
Clinical Pharmacology and Therapeutics
|
August 13, 2021
Response to "Optimized Alectinib Dose Regimen for Treatment of Patients With ALK-Positive NSCLC Based on Robust Pharmacometric Analyses and Clinical Evidence"
Stefanie L Groenland, Dieuwertje R Geel, Jos H Beijnen, et al.
Journal of Otology
|
January 8, 2025
Bilateral squamous cell carcinoma of the temporal bone: A report of two cases and a systematic review of the literature
N Hoogenes, M Tomasoni, P Merkus, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 4, 2014
High-dose, weekly erlotinib is not an effective treatment in EGFR-mutated non-small cell lung cancer-patients with acquired extracranial progressive disease on standard dose erlotinib
J L Kuiper, D A M Heideman, E Thunnissen, et al.
Journal of Biomolecular Screening
|
November 1, 2012
Affordable luciferase reporter assay for cell-based high-throughput screening
Ellen Siebring-van Olst, Christie Vermeulen, Renee X de Menezes, et al.
The Laryngoscope
|
June 14, 2000
High incidence of laryngopharyngeal reflux in patients with head and neck cancer
M P Copper, C F Smit, L D Stanojcic, et al.
The Laryngoscope
|
October 26, 2011
Decision making in advanced otosclerosis: an evidence-based strategy
Paul Merkus, Maarten C van Loon, Conrad F Smit, et al.
Oncogene
|
February 2, 2019
High-throughput RNAi screening reveals cancer-selective lethal targets in the RNA spliceosome
Maxime Blijlevens, Ida H van der Meulen-Muileman, Renée X de Menezes, et al.
Lung Cancer (Amsterdam, Netherlands)
|
June 21, 2016
Personalizing NSCLC therapy by characterizing tumors using TKI-PET and immuno-PET
I Bahce, M Yaqub, E F Smit, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 23, 2016
Repeatability of Quantitative Whole-Body 18F-FDG PET/CT Uptake Measures as Function of Uptake Interval and Lesion Selection in Non-Small Cell Lung Cancer Patients
Gerbrand Maria Kramer, Virginie Frings, Nikie Hoetjes, et al.
Page
of 70
Search research articles
Search
Showing results (231-240 of 692) with videos related to
Sort By:
Page
of 70
The Annals of Thoracic Surgery
|
May 30, 2017
Surgical Treatment of Complications After High-Dose Chemoradiotherapy for Lung Cancer
Chris Dickhoff, Max Dahele, Sayed M Hashemi, et al.
Clinical Pharmacology and Therapeutics
|
August 13, 2021
Response to "Optimized Alectinib Dose Regimen for Treatment of Patients With ALK-Positive NSCLC Based on Robust Pharmacometric Analyses and Clinical Evidence"
Stefanie L Groenland, Dieuwertje R Geel, Jos H Beijnen, et al.
Journal of Otology
|
January 8, 2025
Bilateral squamous cell carcinoma of the temporal bone: A report of two cases and a systematic review of the literature
N Hoogenes, M Tomasoni, P Merkus, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 4, 2014
High-dose, weekly erlotinib is not an effective treatment in EGFR-mutated non-small cell lung cancer-patients with acquired extracranial progressive disease on standard dose erlotinib
J L Kuiper, D A M Heideman, E Thunnissen, et al.
Journal of Biomolecular Screening
|
November 1, 2012
Affordable luciferase reporter assay for cell-based high-throughput screening
Ellen Siebring-van Olst, Christie Vermeulen, Renee X de Menezes, et al.
The Laryngoscope
|
June 14, 2000
High incidence of laryngopharyngeal reflux in patients with head and neck cancer
M P Copper, C F Smit, L D Stanojcic, et al.
The Laryngoscope
|
October 26, 2011
Decision making in advanced otosclerosis: an evidence-based strategy
Paul Merkus, Maarten C van Loon, Conrad F Smit, et al.
Oncogene
|
February 2, 2019
High-throughput RNAi screening reveals cancer-selective lethal targets in the RNA spliceosome
Maxime Blijlevens, Ida H van der Meulen-Muileman, Renée X de Menezes, et al.
Lung Cancer (Amsterdam, Netherlands)
|
June 21, 2016
Personalizing NSCLC therapy by characterizing tumors using TKI-PET and immuno-PET
I Bahce, M Yaqub, E F Smit, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 23, 2016
Repeatability of Quantitative Whole-Body 18F-FDG PET/CT Uptake Measures as Function of Uptake Interval and Lesion Selection in Non-Small Cell Lung Cancer Patients
Gerbrand Maria Kramer, Virginie Frings, Nikie Hoetjes, et al.
Page
of 70